• Whoa… What do you mean you haven’t signed up?

    It is pretty damn easy too. Off to your right just drop in your email and hit submit. The only thing easier are the gains the alerts bring.
    Unlike the other sites, we won't spam the hell out of you. Isn't that sweet? Sit back and enjoy the weekly alerts.

  • Sign Up Today!

BOCX Stock Quote and News

  • Sharebar

BOCX Stock Bio

BioCurex, Inc. is a biotechnology company focused on developing and commercializing products for early cancer diagnosis. The company uses a proprietary blood test based on the RECAF tumor marker. This test can be done at a clinical lab or a doctor’s office very quickly, similar to pregnancy tests available at drug stores.

BOCX Management

Ricardo Moro-Vidal – President, CEO
Denis R. Burger – Chairman
Gladys Chan – CFO

BOCX Stock Overview

BOCX has been in a bit of a downtrend since the first of the year when it was trading over $0.06. BOCX saw some bounces in between but no real big moves. That all changed in September when the company announced that its RECAF blood test for cancer can prevent two thirds of unnecessary prostate biopsies. Following this news BOCX shot up over 100% with huge volume. The company annnounced this news on September 8. BOCX will definitely be an interesting one to watch in days and weeks ahead.

BOCX News

Comments on this entry are closed.